Short Interest in Nanovibronix, Inc. (NASDAQ:FEED) Declines By 85.1%

Nanovibronix, Inc. (NASDAQ:FEED) saw a large drop in short interest during the month of June. As of June 30th, there was short interest totaling 60,839 shares, a drop of 85.1% from the June 15th total of 409,683 shares. Based on an average daily volume of 251,416 shares, the short-interest ratio is currently 0.2 days. Currently, 1.0% of the shares of the company are short sold.

Nanovibronix Stock Performance

FEED stock traded down $0.07 on Monday, reaching $0.46. 500,675 shares of the company’s stock were exchanged, compared to its average volume of 366,226. The company has a fifty day moving average of $0.83. The company has a market cap of $2.79 million, a price-to-earnings ratio of -0.05 and a beta of 1.56. Nanovibronix has a twelve month low of $0.42 and a twelve month high of $17.40.

Nanovibronix (NASDAQ:FEED) last released its earnings results on Monday, May 18th. The company reported ($6.88) EPS for the quarter. The business had revenue of $0.65 million during the quarter. Nanovibronix had a negative net margin of 923.20% and a negative return on equity of 54.25%.

Wall Street Analysts Forecast Growth

Several analysts have recently weighed in on the stock. Wall Street Zen raised shares of Nanovibronix from a “strong sell” rating to a “sell” rating in a report on Sunday. Weiss Ratings restated a “sell (e+)” rating on shares of Nanovibronix in a research report on Friday, April 24th. One investment analyst has rated the stock with a Sell rating, According to data from MarketBeat.com, the stock presently has a consensus rating of “Sell”.

Insider Transactions at Nanovibronix

In other Nanovibronix news, insider Christian Michael Glibert sold 210,000 shares of Nanovibronix stock in a transaction on Monday, June 22nd. The shares were sold at an average price of $0.69, for a total value of $144,900.00. The transaction was disclosed in a document filed with the SEC, which is available through this link. Insiders own 5.20% of the company’s stock.

About Nanovibronix

Nanovibronix (NASDAQ: FEED) is a medical device company focused on the development and commercialization of non?invasive therapeutic ultrasound technologies for clinical and consumer healthcare applications. The company’s product portfolio centers on wearable ultrasound devices designed to deliver low?intensity acoustic energy to soft tissue with the objective of promoting wound healing and reducing pain. Nanovibronix positions its technology as an alternative or adjunct to conventional wound?care and analgesic therapies, aiming to address chronic and acute conditions that are managed in both outpatient and home settings.

The company concentrates its commercial efforts on supplying hospitals, wound?care clinics, long?term care facilities and patients requiring home?based therapies.